Welcome to Chemogen
Chemogen
is an emerging biotechnology company focused on the development
and commercialization of a novel and
proprietary platform technology for the rapid diagnosis of infectious
diseases. The initial application of this technology is in the
area of tuberculosis (“TB”), the world’s deadliest
infectious disease.
Beyond
TB, Chemogen’s
technology provides additional product opportunities
to address global health threats in other
infectious disease areas with significant market opportunities,
including homeland security screening applications.
Our Vision
To become and be recognized as a leader in the
battle against infectious diseases by delivering novel and high
quality diagnostic products to the world.